Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

57.90
Delayed Data
As of Feb 24
 +0.19 / +0.33%
Today’s Change
11.57
Today|||52-Week Range
67.16
+30.35%
Year-to-Date

Today’s Trading

Previous close57.71
Today’s open57.51
Day’s range56.56 - 59.33
Volume1,690,426
Average volume (3 months)2,152,112
Market cap$2.6B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)--
Earnings growth (next 5 years)+29.42%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book616.61

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-0.30-1.39%
IRWDIronwood Pharmaceuti...-0.39-2.32%
HZNPHorizon Pharma PLC+0.30+1.75%
SAGESAGE Therapeutics In...-0.03-0.05%
Data as of 4:00pm ET, 02/24/2017

Financials

Last reporting dateFebruary 22, 2017
EPS forecast (this quarter)-$1.68
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
SVP-Finance, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts


Search for Jobs